AQEMIA
Aqemia is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug candidates for dozens of critical diseases. What sets us apart is our unique quantum and statistical mechanics algorithms fuelling a generative AI to design novel drug candidates. The disruptive speed and accuracy of our technology platform allows us to scale drug discovery projects as technology projects.
AQEMIA
Social Links:
Industry:
Artificial Intelligence (AI) Biotechnology Generative AI Life Science Machine Learning Pharmaceutical
Founded:
2019-06-13
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.aqemia.com
Total Employee:
51+
Status:
Active
Total Funding:
60.1 M EUR
Technology used in webpage:
Domain Not Resolving Amazon HSTS Amazon Virginia Region Amazon Elastic Load Balancing Amazon ELB North Virginia Amazon Elastic Beanstalk
Similar Organizations
Coriell Life Sciences
Coriell Life Sciences delivers the power of precision medicine using pharmacogenomics and clinical decision support software.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Deepbrain AI
Deepbrain AI provides a range of AI powered customer service products.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Pera Labs
Pera Labs develops digiceuticals and AI-powered solutions for fertility.
Proscia
Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.
Valohai
Valohai develops a MLOps platform designed for ML pioneers.
Current Employees Featured
Founder
Investors List
Bpifrance
Bpifrance investment in Series A - AQEMIA
Eurazeo
Eurazeo investment in Series A - AQEMIA
Elaia
Elaia investment in Series A - AQEMIA
Wendel Growth
Wendel Growth investment in Series A - AQEMIA
Eurazeo
Eurazeo investment in Series A - AQEMIA
Bpifrance
Bpifrance investment in Series A - AQEMIA
Elaia
Elaia investment in Series A - AQEMIA
Elaia
Elaia investment in Series A - AQEMIA
Eurazeo
Eurazeo investment in Series A - AQEMIA
Elaia
Elaia investment in Pre Seed Round - AQEMIA
Official Site Inspections
http://www.aqemia.com Semrush global rank: 6.95 M Semrush visits lastest month: 965
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "AQEMIA"
AQEMIA - Crunchbase Company Profile & Funding
AQEMIA is a pharmatech company developing a drug discovery platform to discover new drugs for specific therapeutic targets. Its platform combines quantum-inspired physics and machine …See details»
AQEMIA 2025 Company Profile: Valuation, Funding
AQEMIA General Information Description. Developer of a drug discovery platform designed to discover new drugs for specific therapeutic targets. The …See details»
Aqemia Company Profile - Office Locations, Competitors, Revenue …
Aqemia has 5 employees across 2 locations and $1.1 m in total funding,. See insights on Aqemia including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
AQEMIA: pictures, videos and careers - Welcome to the Jungle
AQEMIA is part of the French Tech 120 and France 2030, spinoff ...See details»
AQEMIA - Funding, Financials, Valuation & Investors - Crunchbase
Oct 17, 2020 AQEMIA is a pharmatech company that develops drug discovery platforms for therapeutic targets. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. …See details»
AQEMIA - Contacts, Employees, Board Members, Advisors
AQEMIA is a pharmatech company that develops drug discovery platforms for therapeutic targets. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. …See details»
Aqemia Company Profile: Funding, Investors & Partnerships
Oct 15, 2022 AQEMIA is France-based silico Drug Company that employs unique science to discover new therapeutic molecules to make the lives of patients better. They use Deep …See details»
AQEMIA Hits $100 Million Funding Milestone, Paving …
Dec 10, 2024 About AQEMIA AQEMIA is a next-gen Techbio company building one of the world's fastest-growing drug discovery pipelines. Our mission is to rapidly design innovative drug candidates for critical ...See details»
AQEMIA Boosts Series A Funding to 60M to Accelerate on its
Organization that embraces generative AI and rigorous physics as key instruments to bring excellence in small molecule drug discovery.”, said ... founder of AQEMIA. About AQEMIA …See details»
Aqemia - Overview, News & Similar companies | ZoomInfo.com
Jun 13, 2024 Who is Aqemia. AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innova tive …See details»
Aqemia Company Information - Funding, Investors, and More
The company Aqemia has raised a total of $67.59m in funding over 3 rounds. Key Insights: Aqemia Series A Round, December 2024: $38m; AQEMIA - Series A round, October 2022: …See details»
AQEMIA - Cathay Innovation
AQEMIA is a next-gen Techbio company building one of the world's fastest-growing drug discovery pipelines. Its mission is to rapidly design innovative drug candidates for critical …See details»
Behind the Term Sheet: AQEMIA’s 38M Funding Round
Dec 10, 2024 Maximilien Levesque and Aqemia epitomize the convergence of quantum physics, AI, and entrepreneurship. As Aqemia continues to teach genAI how to discover new drugs, it …See details»
AQEMIA Hits $100 Million Funding Milestone, Paving Way to …
Dec 10, 2024 AQEMIA is a next-gen Techbio company building one of the world's fastest-growing drug discovery pipelines. Our mission is to rapidly design innovative drug candidates …See details»
Aqemia - Company info. interviews, news - biopharmatrend.com
Aqemia differentiation lies in its affinity prediction both accurate and 10 000x faster than competition, enabling efficient guidance of generation towards compounds with better chances …See details»
Aqemia: the French startup pushes the boundaries of medical …
Jan 13, 2025 Founded in 2019, Aqemia, a young business from the French National Center for Scientific Research (CNRS), is continuing its rise in the field of medicinal product research …See details»
Aqemia Advances Epitranscriptomics Programs and Expands into …
1 day ago About Aqemia. Aqemia is a next-gen TechBio company building one of the world’s fastest-growing drug discovery pipelines. Our mission is to rapidly design innovative drug …See details»
Aqemia Company Information - Funding, Investors, and More
Aqemia, a Paris-based drug discovery platform, demonstrates strong business potential by addressing the slow and costly process of developing new drugs. With a B2B model targeting …See details»
Aqemia wins $32.5m for generative AI-powered drug discovery …
Jan 30, 2024 Paris-based biotech Aqemia has secured €30m ($32.5m) in Series A funding to advance its generative artificial intelligence (AI)-led drug pipeline. The company previously …See details»
AQEMIA Reaches $100 Million in Funding, Plans Expansion and …
Dec 10, 2024 AQEMIA, a techbio company teaching atomic scale physics to a generative AI, has announced reaching $100 million in cumulative funding.The milestone coincides with …See details»